Open access
Open access
Powered by Google Translator Translator

Family Medicine

CDC Report: Acute hepatitis and adenovirus infection among children.

2 May, 2022 | 00:46h | UTC

Acute Hepatitis and Adenovirus Infection Among Children — Alabama, October 2021–February 2022 – Morbidity and Mortality Weekly Report

Commentaries:

CDC releases new clinical details in cases of unusual hepatitis in children – CNN

CDC describes 4 tell-tale physical symptoms of the mysterious liver disease that’s spreading among kids in the US and Europe – Insider

CDC report finds no Covid link in children’s hepatitis cases in Alabama – NBC News

Related:

The CDC and WHO Have Reported an Unusual Cluster of Severe Pediatric Hepatitis Cases – Science-Based Medicine

Investigation into acute hepatitis of unknown aetiology in children in England Technical briefing – UK Health Security Agency

Multi-Country – Acute, severe hepatitis of unknown origin in children – World Health Organization

WHO says 12 countries have reported unusual cases of hepatitis in kids – STAT

CDC Alerts Providers to Hepatitis Cases of Unknown Origin – Centers for Disease Control and Prevention

Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology – Centers for Disease Control and Prevention

Could Mysterious Hepatitis Cases be Triggered by COVID-19? – Health Policy Watch

Increase in hepatitis (liver inflammation) cases in children under investigation – UK Health Security Agency

U.S., U.K. investigating unusual cases of hepatitis in young children – STAT

Acute hepatitis of unknown aetiology – the United Kingdom of Great Britain and Northern Ireland – World Health Organization

Increase in acute hepatitis of unknown origin among children – United Kingdom – European Centre for Disease Prevention and Control

Mysterious liver illness seen in kids in US, Europe – Associated Press

 

Commentaries on Twitter

 


ECDC publishes Rapid Risk Assessment – Increase in severe acute hepatitis cases of unknown etiology in children.

2 May, 2022 | 00:44h | UTC

ECDC publishes Rapid Risk Assessment – Increase in severe acute hepatitis cases of unknown aetiology in children – European Centre for Disease Prevention and Control

Related:

The CDC and WHO Have Reported an Unusual Cluster of Severe Pediatric Hepatitis Cases – Science-Based Medicine

Investigation into acute hepatitis of unknown aetiology in children in England Technical briefing – UK Health Security Agency

Multi-Country – Acute, severe hepatitis of unknown origin in children – World Health Organization

WHO says 12 countries have reported unusual cases of hepatitis in kids – STAT

CDC Alerts Providers to Hepatitis Cases of Unknown Origin – Centers for Disease Control and Prevention

Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology – Centers for Disease Control and Prevention

Could Mysterious Hepatitis Cases be Triggered by COVID-19? – Health Policy Watch

Increase in hepatitis (liver inflammation) cases in children under investigation – UK Health Security Agency

U.S., U.K. investigating unusual cases of hepatitis in young children – STAT

Acute hepatitis of unknown aetiology – the United Kingdom of Great Britain and Northern Ireland – World Health Organization

Increase in acute hepatitis of unknown origin among children – United Kingdom – European Centre for Disease Prevention and Control

Mysterious liver illness seen in kids in US, Europe – Associated Press

 


RCT: Phentermine/Topiramate for the treatment of adolescent obesity.

2 May, 2022 | 00:41h | UTC

Phentermine/Topiramate for the Treatment of Adolescent Obesity – NEJM Evidence

 

Commentary on Twitter

 


Consensus Recommendations: Quality standards for the management of non-alcoholic fatty liver disease.

2 May, 2022 | 00:21h | UTC

Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group – The Lancet Gastroenterology & Hepatology (free registration required)

Related Guidelines:

Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association – Arteriosclerosis, Thrombosis, and Vascular Biology

Advancing the global public health agenda for NAFLD: a consensus statement – Nature Reviews Gastroenterology & Hepatology

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease – Gastroenterology

Non-alcoholic fatty liver disease: A patient guideline – JHEP Reports

 


NICE chronic primary pain guidelines: what the busy GP needs to know.

2 May, 2022 | 00:25h | UTC

NICE chronic primary pain guidelines: what the busy GP needs to know – British Journal of General Practice

Original Guideline: Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain – National Institute for Health and Care Excellence

 


Guideline: Management of alcohol-related liver disease.

1 May, 2022 | 23:34h | UTC

Management of alcohol-related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines – Liver International

 


10-year results of a RCT: Effects of parathyroidectomy vs. observation on morbidity and mortality in patients with mild primary hyperparathyroidism.

1 May, 2022 | 23:22h | UTC

Mortality and Morbidity in Mild Primary Hyperparathyroidism: Results From a 10-Year Prospective Randomized Controlled Trial of Parathyroidectomy Versus Observation – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentary: Parathyroidectomy No Better for Mild Primary Hyperparathyroidism – HealthDay

 

Commentary on Twitter

 


M-A: Comparative safety and efficacy of cognitive enhancers for Alzheimer’s dementia.

1 May, 2022 | 23:10h | UTC

Comparative safety and efficacy of cognitive enhancers for Alzheimer’s dementia: a systematic review with individual patient data network meta-analysis – BMJ Open

 


RCT: Extended vs. standard antibiotic course duration in children below 5 years of age hospitalized with community-acquired pneumonia in high-risk settings.

29 Apr, 2022 | 11:16h | UTC

Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial – The Pediatric Infectious Disease Journal

Related:

Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial – JAMA Pediatrics

Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians – Annals of Internal Medicine

Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial – JAMA Pediatrics

Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial – JAMA

Treatment of UTIs in Infants <2 Months: A Living Systematic Review – Hospital Pediatrics

Effect of 7 vs 14 Days of Antibiotic Therapy on Resolution of Symptoms Among Afebrile Men With Urinary Tract Infection: A Randomized Clinical Trial – JAMA

Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial – Clinical Infectious Diseases

Efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults: A systematic review and meta-analysis – Antimicrobial Agents and Chemotherapy

 

Commentary on Twitter

 


WHO reveals shocking extent of exploitative formula milk marketing.

29 Apr, 2022 | 10:58h | UTC

News Release: WHO reveals shocking extent of exploitative formula milk marketing – World Health Organization

Report: Scope and impact of digital marketing strategies for promoting breastmilk substitutes – World Health Organization

Related: More than half of parents and pregnant women exposed to aggressive formula milk marketing – WHO, UNICEF – World Health Organization

 

Commentary on Twitter (thread – click for more)

 


Hepatitis outbreak in children: explainer on adenovirus type 41, the possible culprit.

29 Apr, 2022 | 11:07h | UTC

Hepatitis outbreak in children: explainer on adenovirus type 41, the possible culprit – The Conversation

Related:

Investigation into acute hepatitis of unknown aetiology in children in England Technical briefing – UK Health Security Agency

Multi-Country – Acute, severe hepatitis of unknown origin in children – World Health Organization

WHO says 12 countries have reported unusual cases of hepatitis in kids – STAT

CDC Alerts Providers to Hepatitis Cases of Unknown Origin – Centers for Disease Control and Prevention

Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology – Centers for Disease Control and Prevention

Could Mysterious Hepatitis Cases be Triggered by COVID-19? – Health Policy Watch

Increase in hepatitis (liver inflammation) cases in children under investigation – UK Health Security Agency

U.S., U.K. investigating unusual cases of hepatitis in young children – STAT

Acute hepatitis of unknown aetiology – the United Kingdom of Great Britain and Northern Ireland – World Health Organization

Increase in acute hepatitis of unknown origin among children – United Kingdom – European Centre for Disease Prevention and Control

Mysterious liver illness seen in kids in US, Europe – Associated Press

 


The Lancet Series: Optimizing child and adolescent health and development.

29 Apr, 2022 | 10:55h | UTC

Homepage: Optimising Child and Adolescent Health and Development – The Lancet (free registration required for all articles)

Health and development from preconception to 20 years of age and human capital

Effects of early-life poverty on health and human capital in children and adolescents: analyses of national surveys and birth cohort studies in LMICs

What can work and how? An overview of evidence-based interventions and delivery strategies to support health and human development from before conception to 20 years

Improving health and social systems for all children in LMICs: structural innovations to deliver high-quality services

Optimising child and adolescent health and development in the post-pandemic world

Opportunities in crisis for optimising child health and development

 


Varicose veins: what can be done to help?

29 Apr, 2022 | 10:49h | UTC

Varicose veins: what can be done to help? – Evidently Cochrane

Related:

Graduated compression stockings for the initial treatment of varicose veins in people without venous ulceration – Cochrane Library

Interventions for great saphenous vein incompetence – Cochrane Library

Surgery for deep venous insufficiency – Cochrane Library

CHIVA method for the treatment of chronic venous insufficiency – Cochrane Library

Injection sclerotherapy for varicose veins – Cochrane Library

 


Expert Consensus: Topical treatment of recurrent vulvovaginal candidiasis.

29 Apr, 2022 | 10:46h | UTC

Topical Treatment of Recurrent Vulvovaginal Candidiasis: An Expert Consensus – Women’s Health Reports

 


Study Commentary | People of all ages benefit from drugs to lower blood pressure.

29 Apr, 2022 | 08:18h | UTC

People of all ages benefit from drugs to lower blood pressure – National Institute for Health and Care Research

Original Study: Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis – The Lancet

 


RCT: Effect of an interdisciplinary weight loss and lifestyle intervention on obstructive sleep apnea severity.

29 Apr, 2022 | 08:14h | UTC

Effect of an Interdisciplinary Weight Loss and Lifestyle Intervention on Obstructive Sleep Apnea Severity: The INTERAPNEA Randomized Clinical Trial – JAMA Network Open

Commentary: Weight Loss, Lifestyle Interventions Improve Obstructive Sleep Apnea – HCP Live

 

Commentary on Twitter

 


Analysis | Presenting complaint: use of language that disempowers patients.

28 Apr, 2022 | 11:02h | UTC

Presenting complaint: use of language that disempowers patients – The BMJ

News Release: Language that belittles or blames patients is overdue for change – British Medical Journal

 


Development and validation of the symptom burden questionnaire for long covid (SBQ-LC): Rasch analysis.

28 Apr, 2022 | 10:56h | UTC

Development and validation of the symptom burden questionnaire for long covid (SBQ-LC): Rasch analysis – The BMJ

 

Commentary on Twitter

https://twitter.com/bmj_latest/status/1519430941759918080

 


Study Commentary | Palliative and end of life care should not wait for a prediction of death.

28 Apr, 2022 | 10:44h | UTC

Palliative and end of life care should not wait for a prediction of death – National Institute for Health and Care Research

Original Study: Timely community palliative and end-of-life care: a realist synthesis – BMJ Supportive & Palliative Care

 


Guideline: Management of small renal masses.

28 Apr, 2022 | 10:36h | UTC

Canadian Urological Association guideline: Management of small renal masses – Canadian Urological Association Journal

See also: Summary of Recommendations

 


Study Commentary | Restricting calories leads to weight loss, not necessarily the window of time you eat them in.

28 Apr, 2022 | 08:12h | UTC

Restricting calories leads to weight loss, not necessarily the window of time you eat them in – The Conversation

Original Study: Calorie Restriction with or without Time-Restricted Eating in Weight Loss- New England Journal of Medicine

 


Podcast: Lower urinary tract symptoms, benign prostatic hyperplasia, and urinary incontinence.

28 Apr, 2022 | 08:00h | UTC

LUTS, BPH, and Urinary Incontinence Triple Distilled – The Curbsiders

 


USPSTF Recommendation Statement: Aspirin Use to Prevent Cardiovascular Disease.

27 Apr, 2022 | 08:16h | UTC

Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement – JAMA

Author Interview: USPSTF Recommendation: Aspirin Use for Cardiovascular Disease – JAMA

Modeling Study: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force – JAMA

Evidence Report: Aspirin Use to Prevent Cardiovascular Disease and Colorectal CancerUpdated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Patient Page: Use of Aspirin to Prevent Cardiovascular Disease – JAMA

Editorials:

Should Patients Take Aspirin for Primary Cardiovascular Prevention? Updated Recommendations From the US Preventive Services Task Force

Whom to Treat for Primary Prevention of Atherosclerotic Cardiovascular Disease: The Aspirin Dilemma – JAMA Internal Medicine

Aspirin for Primary Prevention—Time to Rethink Our Approach – JAMA Network Open

USPSTF Report on Aspirin for Primary Prevention – JAMA Cardiology

Commentaries:

USPSTF Report on Aspirin for Primary Prevention – American College of Cardiology

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention – TCTMD

Daily aspirin offers little to no benefit for most adults trying to prevent heart disease, new report says – STAT

U.S. Task Force Rejects Daily Aspirin for Heart Health in People Over 60 – HealthDay

 


NICE Guideline: Epilepsies in children, young people and adults.

27 Apr, 2022 | 08:14h | UTC

Epilepsies in children, young people and adults – National Institute for Health and Care Excellence

 


Clinical Review: Diagnosis and management of covid-19 in pregnancy.

27 Apr, 2022 | 08:13h | UTC

Diagnosis and management of covid-19 in pregnancy – The BMJ

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.